No black box warning on record for Everolimus

As of the latest FDA labeling reviewed, Everolimus (EVEROLIMUS) does not carry a black box warning. Standard warnings and precautions still apply — see the full Everolimus medicine page for the complete safety profile.

Other warnings & precautions

5. WARNINGS AND PRECAUTIONS Non-Infectious Pneumonitis: Monitor for clinical symptoms or radiological changes. Withhold or permanently discontinue based on severity. ( 2.9 , 5.1 ) Infections: Monitor for signs and symptoms of infection. Withhold or permanently discontinue based on severity. ( 2.9 , 5.2 ) Severe Hypersensitivity Reactions: Permanently discontinue for clinically significant hypersen

No black box warning on record for Everolimus

Other warnings & precautions

5. WARNINGS AND PRECAUTIONS Non-Infectious Pneumonitis: Monitor for clinical symptoms or radiological changes. Withhold or permanently discontinue based on severity. ( 2.9 , 5.1 ) Infections: Monitor for signs and symptoms of infection. Withhold or permanently discontinue based on severity. ( 2.9 , 5.2 ) Severe Hypersensitivity Reactions: Permanently discontinue for clinically significant hypersen

Everolimus Black Box Warning

No black box warning on record for Everolimus

Other warnings & precautions

Everolimus Black Box Warning

No black box warning on record for Everolimus

Other warnings & precautions